DelveInsight's D-Dimer Testing Market Insights report provides the current and forecast market analysis, individual leading D ...

The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise ...

“Onco360 is grateful for the opportunity to partner with the team at Genentech and become a specialty pharmacy provider for Itovebi ™ ,” said Benito Fernandez. “We are proud to add another treatment ...

Also Read: Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain Adjusted operating income for the quarter was $441.1 million, or 13.4% of revenue ...

The global antimicrobial susceptibility testing market is projected to reach USD 5.68 billion by 2029 from USD 4.45 billion in 2024, growing at a CAGR of 5.0% % during the forecast period. Major ...

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

The global drug-induced immune hemolytic anemia market, valued at approximately USD 7.8 billion in 2023, is poised for ...

Separately, Roche's chief medical officer and head of global product development Levi Garraway, has been appointed to an enlarged corporate ... and a 3% increase for diagnostics to CHF 17.7 ...

In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK ... manufacture, and market diagnostic ...

The Minimal Residual Disease Testing Market is projected to reach $4.45 billion by 2031, at a CAGR of 14.6% during the forecast period 2024–2031. The growth of the minimal residual disease testing ...